Cancer chemotherapy agents target intratumoral dendritic cells to potentiate antitumor immunity.
- Published in:
- OncoImmunology, 2014, v. 3, n. 8, p. N.PAG, doi. 10.4161/21624011.2014.954460
- By:
- Publication type:
- Article
Works matching DE "DOLASTATIN"
Results: 7
1
2
Monomethyl auristatin E Exhibits Potent Cytotoxic Activity against Human Cancer Cell Lines SKBR3 and HEK293.
- Published in:
- Novelty in Biomedicine, 2017, v. 5, n. 4, p. 145
- By:
- Publication type:
- Article
3
Mechanism of mitotic arrest induced by dolastatin 15 involves loss of tension across kinetochore pairs.
- Published in:
- Molecular & Cellular Biochemistry, 2013, v. 382, n. 1/2, p. 93, doi. 10.1007/s11010-013-1721-8
- By:
- Publication type:
- Article
4
Phase II trial of dolastatin-10, a novel anti-tubulin agent, in metastatic soft tissue sarcomas.
- Published in:
- Sarcoma, 2004, v. 8, n. 4, p. 107, doi. 10.1155/2004/924913
- By:
- Publication type:
- Article
5
Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugates.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 3, p. 439, doi. 10.1007/s00280-012-1925-8
- By:
- Publication type:
- Article
6
Theoretical Comparison between Structural and Dynamical Features of Dolastatins 11 and 12 Antineoplastic Depsipeptides.
- Published in:
- SAR & QSAR in Environmental Research, 2003, v. 14, n. 5/6, p. 475, doi. 10.1080/10629360310001624042
- By:
- Publication type:
- Article
7
Conformational behavior of antineoplastic peptides Dolastatin 10 and Dolastatin 15 from Monte Carlo and molecular dynamics simulations.
- Published in:
- International Journal of Quantum Chemistry, 2007, v. 107, n. 2, p. 318, doi. 10.1002/qua.21195
- By:
- Publication type:
- Article